Sionna Therapeutics, Inc. Common Stock SION
$6.46
-1.22%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 8-K | 8-K | 2026-08-10 | View → |
| 10-Q | 10-Q | 2026-08-06 | View → |
| 8-K | 8-K | 2026-08-06 | View → |
| 4 | Insider transaction | 2026-07-09 | View → |
| 4 | Insider transaction | 2026-07-09 | View → |
| 4 | PRIMARY DOCUMENT | 2026-07-07 | View → |
| 4 | Insider transaction | 2026-07-02 | View → |
| 4 | Insider transaction | 2026-07-02 | View → |
| 4 | PRIMARY DOCUMENT | 2026-06-18 | View → |
| 4 | PRIMARY DOCUMENT | 2026-06-18 | View → |
| 4 | PRIMARY DOCUMENT | 2026-06-18 | View → |
| 4 | Insider transaction | 2026-06-18 | View → |
| 4 | PRIMARY DOCUMENT | 2026-06-18 | View → |
| 4 | PRIMARY DOCUMENT | 2026-06-18 | View → |
| 4 | PRIMARY DOCUMENT | 2026-06-18 | View → |
| 4 | PRIMARY DOCUMENT | 2026-06-18 | View → |
| 4 | PRIMARY DOCUMENT | 2026-06-18 | View → |
| 8-K | 8-K | 2026-06-18 | View → |
| 4 | Insider transaction | 2026-05-29 | View → |
| 4 | Insider transaction | 2026-05-29 | View → |
| 10-Q | 10-Q | 2026-05-12 | View → |
| 8-K | 8-K | 2026-05-12 | View → |
| 4 | Insider transaction | 2026-05-11 | View → |
| 4 | Insider transaction | 2026-05-11 | View → |
| DEF 14A | DEF 14A | 2026-04-27 | View → |
| 4 | Insider transaction | 2026-04-21 | View → |
| 4 | Insider transaction | 2026-04-21 | View → |
| 4 | Insider transaction | 2026-04-16 | View → |
| 4 | Insider transaction | 2026-04-16 | View → |
| 4 | PRIMARY DOCUMENT | 2026-03-06 | View → |
| 10-K | 10-K | 2026-03-02 | View → |
| 8-K | 8-K | 2026-03-02 | View → |
| 4 | Insider transaction | 2026-02-04 | View → |
| 4 | Insider transaction | 2026-02-04 | View → |
| 4 | Insider transaction | 2026-01-26 | View → |
| 4 | PRIMARY DOCUMENT | 2026-01-06 | View → |
| 4 | PRIMARY DOCUMENT | 2026-01-06 | View → |
| 4 | PRIMARY DOCUMENT | 2026-01-06 | View → |
| 4 | PRIMARY DOCUMENT | 2026-01-06 | View → |
| 4 | PRIMARY DOCUMENT | 2026-01-06 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $6.46
- Market Cap
- $282.58 million
- 52-Week Range
- $4.01 – $54.97
- Average Volume
- 2.88 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.